Prescription drug · NDA
ELYXYB - celecoxib (celecoxib) NDC 69557-333
Celecoxib 120 mg/4.8mL · Liquid · Oral · SCILEX PHARMACEUTICALS INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69557-333-01 | 69557033301 | 6 BOTTLE in 1 CARTON (69557-333-01) / 4.8 mL in 1 BOTTLEMarketed from Nov 27, 2023 | |
| 69557-333-02 | 69557033302 | 1 BOTTLE in 1 CARTON (69557-333-02) / 4.8 mL in 1 BOTTLEMarketed from Nov 27, 2023 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ELYXYB - celecoxib
- Generic name (nonproprietary)
- celecoxib
- Active ingredients
- Celecoxib — 120 mg/4.8mL
- Dosage form
- Liquid
- Route
- Oral
- Labeler
- SCILEX PHARMACEUTICALS INC.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 212157
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
- Identifiers
- Product ID 69557-333_ad5c6af3-1790-4a13-b4e5-6e3af543b2a8SPL ID ad5c6af3-1790-4a13-b4e5-6e3af543b2a8SPL set ID c8a5de07-9f27-4a54-a885-8089f0307bd7RxCUI 2373454, 2373460UNII JCX84Q7J1L
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469557033301followed by a unit qualifier and the quantityPackage 69557-0333-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
ELYXYB is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use ELYXYB is not indicated for the preventive treatment of migraine. ELYXYB is a nonsteroidal anti-inflammatory drug indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use ELYXYB is not indicated for the preventive treatment of migraine. ( 1 )
Excerpt only. Read the full label for complete information.